RCT-001

N/A

Report date: 2023/05/11 13:42:13
NME

Base Information

Drug NameRCT-001
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsUveal melanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRoca Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesRoca Therapeutics
Inactive CompaniesN/A
Active IndicationsUveal melanoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A